BBOTVSPFSA• 12 Months (Normalized)
BBOT vs PFSA (BridgeBio Oncology Therapeutics Inc. vs Profusa Inc.)
Showing Closing Date Range from Oct 5, 2025 to Oct 5, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
BBOT Performance $3.89
-68.95%
BridgeBio Oncology Therapeutics Inc.
Normalized Baseline0.00%
PFSA Performance $1.69
-99.94%
Profusa Inc.
Normalized Baseline0.00%
Alpha Spread Margin BBOT LEADS
+30.99 pts
BBOT outperforming by 30.99 percentage points
BBOTPFSA
Spread Trajectory12 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
BBOT PFSA
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(249 dates)
| Date | BBOT Price | BBOT Gain (%) | PFSA Price | PFSA Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 02, 2026 | $3.89 | -68.95% | $1.69 | -99.94% | +30.99% |
| Sep 30, 2026 | $4.10 | -67.28% | $1.98 | -99.93% | +32.65% |
| Sep 29, 2026 | $3.92 | -68.72% | $2.27 | -99.91% | +31.19% |
| Sep 28, 2026 | $3.81 | -69.59% | $1.69 | -99.94% | +30.35% |
| Sep 25, 2026 | $3.95 | -68.48% | $2.18 | -99.92% | +31.44% |
| Sep 24, 2026 | $3.99 | -68.16% | $3.03 | -99.89% | +31.73% |
| Sep 23, 2026 | $4.16 | -66.80% | $2.05 | -99.92% | +33.12% |
| Sep 22, 2026 | $4.66 | -62.81% | $2.17 | -99.92% | +37.11% |
| Sep 21, 2026 | $4.66 | -62.81% | $1.94 | -99.93% | +37.12% |
| Sep 18, 2026 | $4.77 | -61.93% | $1.91 | -99.93% | +38.00% |
| Sep 17, 2026 | $4.89 | -60.97% | $1.80 | -99.93% | +38.96% |
| Sep 16, 2026 | $4.76 | -62.01% | $1.78 | -99.93% | +37.92% |
| Sep 15, 2026 | $4.88 | -61.05% | $1.83 | -99.93% | +38.88% |
| Sep 14, 2026 | $5.05 | -59.70% | $2.59 | -99.90% | +40.20% |
| Sep 11, 2026 | $4.95 | -60.49% | $2.43 | -99.91% | +39.42% |
Page 1 of 17